Sort
8,912 grants matching “sars cov 2”
SARS-CoV-2 Pathogenesis
$169,908Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
SIV zoonosis using humanized mice
$169,880Ramesh Akkina · Colorado State University · R21 · FY2024 · AI
Bioinformatics Studies of Human Viruses
$169,822John Spouge · National Library Of Medicine · ZIA · FY2021 · LM
Development of Sustained-Release Anti-coronavirus Nucleoside Phosphonate compounds
$169,785Robert Turner Schooley · University Of California, San Diego · R01 · FY2021 · AI
T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade
$169,500Michelle Krogsgaard · New York University School Of Medicine · R01 · FY2020 · CA
Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancer
$169,500Leopoldo Nicolas Segal · New York University School Of Medicine · R37 · FY2020 · CA
The effects of immunosuppression on SARS-CoV-2 persistence, virus genetic diversity and clinical outcomes of COVID-19
$169,500Mirella Salvatore · New York University School Of Medicine · R21 · FY2025 · AI
7T Neurosurgical Mapping Protocol for Endoscopic Resection of Skull Base Tumors
$169,495Priti Balchandani · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
A Structure-based Drug Discovery Effort to Combat COVID-19 and Future Outbreaks
$169,420Marta Filizola · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DA
Modeling and data analysis of obesity, insulin resistance, and diabetes
$169,181Carson Chow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center, SARS-CoV-2
$169,106Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2024 · AI
Individualizing Steroid Use in Pneumonia
$169,020Yewande Odeyemi · Mayo Clinic Rochester · K23 · FY2023 · HL
Genetic Investigation of Covid 19 in Lung Disease
$168,935Mark L Kahn · University Of Pennsylvania · R01 · FY2023 · HL
Developing a resiliency intervention to support healthcare workers engaged in the provision of HIV care
$168,824Christina Psaros · Massachusetts General Hospital · R34 · FY2024 · MH
Feasibility of pharmacy-delivered patient navigation + virtual buprenorphine + HIV services
$168,781Crystal M Fuller · New York University School Of Medicine · R34 · FY2024 · DA
Surfaceome CRISPR screening for SARS-CoV-2 virulent proteins
$168,651Sanghyun Lee · Brown University · P20 · FY2023 · GM
Effect of SARS-CoV-2 on clinical course and NK cells in patients receiving immunotherapy
$168,429Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
COVID Global Mix - Global Mix / Investigation of COVID-19 Disease Parameters for Transmission Models in Low-Resource Settings
$168,350Saad B. Omer · Ut Southwestern Medical Center · R01 · FY2025 · AI
Role of Interferon lambda signaling in mucosal homeostasis and infantile-onset inflammatory bowel disease
$168,005Jodie Ouahed · Boston Children'S Hospital · K08 · FY2023 · DK
Role of Interferon lambda signaling in mucosal homeostasis and infantile-onset inflammatory bowel disease
$168,005Jodie Ouahed · Boston Children'S Hospital · K08 · FY2024 · DK
Characterizing the Functional Architecture of the Necklace Olfactory System
$167,984Sandeep R Datta · Harvard Medical School · R01 · FY2020 · DC
Architecture and interactions of Granzyme K+ CD8 T cells in inflamed synovium in rheumatoid arthritis
$167,875Anna Helena Jonsson · University Of Colorado Denver · K08 · FY2024 · AR
Study of and development of antiviral drugs against SARS-CoV2 protease
$167,849Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
RAPID: COVID-19: Sterilization Mechanism of Corona Discharge for Masks and Environment
$167,568Ying Zhong · University Of South Florida · · FY2020 · ENG
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
$167,500Michael H Nathanson · Yale University · R01 · FY2022 · AA